Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Aldeyra Therapeutics (137) Ownership - Who Owns Aldeyra Therapeutics?
0 Followers
Aldeyra Therapeutics (137) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.27% Other Institutional Investors
98.73% Public Companies and
Individual Investors
The ownership structure of Aldeyra Therapeutics (DE:137) stock is a mix of institutional, retail and individual investors. Approximately 1.27% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 08, 2024 | Perceptive Advisors Llc >10% Owner | Bought | $833867 |
| Apr 03, 2024 | Perceptive Advisors Llc >10% Owner | Bought | $1934505 |
| Mar 12, 2024 | Bruce Greenberg Interim Cfo | Sold | $44883 |
| Mar 12, 2024 | Sold | $61985 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $30163486 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,248 | Insider | ― | 102,625 | |
| 23,967 | Insider | ― | 87,072 | |
| 15,500 | Insider | ― | 56,312 | |
| 15,854 | Insider | ― | 57,598 | |
| 1,471,298 | Insider | ― | 5,345,226 | |
| 14,812 | Insider | ― | 53,812 | |
| 8,563 | Insider | ― | 31,109 | |
| 1,885,854 | Insider | ― | 6,851,308 | |
| 9,275,851 | Insider | ― | 33,699,167 | |
| 2 | Institution | ― | 8 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 784,037 | Institution | ― | 3,048,336 | |
| 750,069 | Institution | ― | 2,916,268 | |
| 487,758 | Institution | ― | 1,896,403 | |
| 585,002 | Institution | ― | 2,274,488 | |
| 10,793 | Institution | ― | 41,963 | |
| 21,063 | Institution | ― | 81,893 | |
| 37,257 | Institution | ― | 144,855 | |
| 30,421 | Institution | ― | 118,277 | |
| 1,589 | Institution | ― | 6,178 | |
| 1,127 | Institution | ― | 4,382 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aldeyra Therapeutics (DE:137)?
According to the latest TipRanks data, approximately 1.27% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 98.73% is held by retail investors.
What percentage of Aldeyra Therapeutics (DE:137) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.27% of Aldeyra Therapeutics (DE:137) stock is held by institutional investors.
What percentage of Aldeyra Therapeutics (DE:137) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.73% of Aldeyra Therapeutics (DE:137) stock is held by retail investors.
Who owns the most shares of Aldeyra Therapeutics (DE:137)?
Ben Bronstein owns the most shares of Aldeyra Therapeutics (DE:137).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.